<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7196187\results\search\zoonosis\results.xml">
  <result pre="Convalescent plasma (CP) COVID-19 Current diagnostics SARS-CoV-2 INTRODUCTION The novel" exact="coronavirus disease 2019" post="(COVID-19), an outbreak caused by the Severe Acute Respiratory"/>
  <result pre="This is the third coronavirus epidemic after the SARS and" exact="MERS coronavirus" post="outbreaks. Structural studies revealed that there is a close"/>
  <result pre="important specimen recommended by the WHO and CDC to detect" exact="SARS-CoV-2 infection" post="is the OP. This swab is collected from the"/>
  <result pre="single vial for more sensitive and appropriate results of the" exact="SARS-CoV-2 infection." post="Bronchoalveolar lavage and tracheal aspirate: For patients who are"/>
  <result pre="and IgG antibodies produced by the patient in response to" exact="SARS-CoV-2 infection" post="(9). Likewise, ICMR has also issued some guidelines for"/>
  <result pre="beta-1a, chloroquine, and hydroxychloroquine. Remdesivir has been previously tested for" exact="Ebola" post="treatment (15). According to a recent study, an inflammatory"/>
  <result pre="therapy appears as a shaft of light to combat the" exact="SARS-CoV-2 infection." post="Doctors and scientists are claiming that CP therapy was"/>
  <result pre="treat several infectious diseases, including Spanish flu (1917-1918) (32), the" exact="Ebola" post="epidemic in West Africa (33), human coronaviruses (34), influenza"/>
  <result pre="(37, 38). In a meta-analysis from 32 studies conducted on" exact="SARS-CoV infection," post="the mortality rate was significantly decreased when compared to"/>
  <result pre="be approved soon as the one-stop remedy to treat the" exact="SARS-CoV-2 infection." post="As per the government order, more state hospitals should"/>
  <result pre="mild symptom associated with this disease. Containing the spread of" exact="SARS-CoV-2 infection" post="will potentially reduce the stress and strain on the"/>
  <result pre="are working rigorously to find the solution to treat the" exact="SARS-CoV-2 infection" post="at a rapid pace. Hence, more research is needed"/>
  <result pre="for collecting, handling, and testing clinical specimens from persons for" exact="coronavirus disease 2019" post="(COVID-19)https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.htmlaccessed on 16 April, 2020 9collab: World Health Organization"/>
  <result pre="Intern Med14559960910.7326/0003-4819-145-8-200610170-0013916940336 33Van GriensvenJEdwardsTde LamballerieXet al.2016Evaluation of convalescent plasma for" exact="Ebola" post="virus disease in GuineaN Engl J Med374334210.1056/NEJMoa151181226735992 34ZhouBZhongNGuanY2007Treatment with"/>
  <result pre="Infect Dis5244745610.1093/cid/ciq10621248066 37ChengZLuYCaoQet al.2020Clinical features and chest CT manifestations of" exact="coronavirus disease 2019" post="(COVID-19) in a single-center study in Shanghai, ChinaAm J"/>
  <result pre="a less toxic derivative of chloroquine, is effective in inhibiting" exact="SARS-CoV-2 infection" post="in vitroCell Discov61610.1038/s41421-020-0156-032194981 Fig. 1 Collection of Specimens/samples and"/>
  <result pre="Ninth Hospital of Nanchang Nanchang, Jiangxi, China Eculizumab (Soliris) in" exact="Covid-19" post="Infected Patients Eculizumab Initiated - Norwegian Coronavirus Disease 2019"/>
  <result pre="Acyclovir SARS, MERS, Coronavirus 229E and COVID-19 Nitazoxanide SARS, MERSand" exact="Influenza" post="Influenza drugs MERS Remdesivir COVID-19, SARS, MERS Favipiravir COVID-19"/>
  <result pre="SARS, MERS, Coronavirus 229E and COVID-19 Nitazoxanide SARS, MERSand Influenza" exact="Influenza" post="drugs MERS Remdesivir COVID-19, SARS, MERS Favipiravir COVID-19 Darunavir"/>
  <result pre="Ruxolitinib COVID-19 Saquinavir SARS and Feline Coronavirus Relenza, Tamiflu, Amantadine" exact="Influenza" post="virus Indinavir SARS and COVID-19 Carfilzomib COVID-19 Oseltamivir COVID-19"/>
  <result pre="investigation in clinical trials for pre-exposure or post-exposure prophylaxis of" exact="SARS-CoV-2 infection," post="and treatment of patients with mild, moderate, and severe"/>
  <result pre="al., 2020) Two drugs, remdesivir and chloroquine phosphate, efficiently inhibited" exact="SARS-CoV-2 infection" post="in vitro Remdesivir + chloroquine phosphate Not specified 27"/>
 </snippets>
</snippetsTree>
